Company Overview
Ucb (Investments) Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Wednesday 04 April 1973, so this is a well established company. Ucb (Investments) Limited has been in business for 52 years and 11 months. The accounts status is full and the accounts are next due on Wednesday 30 September 2026.
Registered Address

208 Bath Road, Slough, Berkshire, SL1 3WE
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameUCB (INVESTMENTS) LIMITED
Company Number01106309
Registered Office Address208 Bath Road
 Slough
 SL1 3WE
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date04/04/1973
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryFULL
Returns Next Due Date17/08/2016
Returns Last Made Up Date20/07/2015
Directors & Members
Show Resigned
Yogesh Khatri - Director
(British, 61 years old, born October 1965)
Appointed 24 June 2013
 Active
Nico Reynders - Director
(Belgian, 54 years old, born August 1972)
Appointed 01 December 2024
 Active
Secretaries
Show Resigned
Other Company Directorships
Yogesh Khatri
CELLTECH GROUP LIMITED
CELLTECH JAPAN LIMITED
CELLTECH LIMITED
CELLTECH PENSION TRUSTEES LIMITED
CELLTECH PHARMA EUROPE LIMITED
CELLTECH R&D LIMITED
CHIROSCIENCE GROUP LIMITED
CHIROSCIENCE R&D LIMITED
CONFIRMANT LIMITED
DARWIN DISCOVERY LIMITED
EVANS HEALTHCARE LIMITED
FIPAR
FIPAR UK LIMITED
INTERNATIONAL MEDICATION SYSTEMS (U.K.) LIMITED
KAPURE LTD
MEDEVA INTERNATIONAL LIMITED
MEDEVA LIMITED
MEDEVA UK PENSION LIMITED
OXFORD GLYCOSCIENCES
OXFORD GLYCOSCIENCES (UK) LIMITED
SCHWARZ PHARMA LIMITED
UCB BRIDGWATER PENSION TRUST LIMITED
UCB BRITISH PENSION TRUST LIMITED
UCB FIPAR LIMITED
UCB IRELAND
UCB PHARMA LIMITED
UCB WATFORD LIMITED
VIKING TRADING CO. LIMITED
ZOGENIX EUROPE LIMITED
ZOGENIX INTERNATIONAL LIMITED
Nico Reynders
CELLTECH GROUP LIMITED
CELLTECH R&D LIMITED
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY
UCB PHARMA LIMITED
ZOGENIX EUROPE LIMITED
ZOGENIX INTERNATIONAL LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Balance Sheet
Fixed Assets 938,153,000 938,153,000 23,397,000
Current Assets 24,416,000 24,416,000 30,075,000
Creditors Due Within One Year 1,547,000 1,547,000 3,685,000
Working Cap 22,869,000 22,869,000 26,390,000
Total Assets Less Current Liabilities 961,022,000 961,022,000 49,787,000
Long-term Liabilities 2,024,000 2,024,000 4,127,000
Net Assets 958,998,000 958,998,000 45,660,000
Share Capital & Reserves
Share Cap 45,928,000 45,928,000 44,928,000
Profit & Loss Reserves -2,734,000 -2,734,000 732,000
Other Reserves 915,804,000 915,804,000 0
Shareholders Funds 958,998,000 958,998,000 45,660,000
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Tangible Fixed Assets - - -
Fixed Assets 97.5% 97.5% 43.8%
Stocks Inventory 0.0% 0.0% 0.0%
Debtors 2.3% 2.3% 43.1%
Cash Bank In Hand 0.2% 0.2% 13.1%
Current Assets 2.5% 2.5% 56.2%
Creditors Due Within One Year 0.2% 0.2% 6.9%
Net Current Assets Liabilities 2.4% 2.4% 49.4%
Creditors Due After One Year 0.0% 0.0% 0.0%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 99.6% 99.6% 85.4%
Called Up Share Capital 4.8% 4.8% 84.0%
Share Capital Allotted Called Up Paid 4.8% 4.8% 84.0%
Profit Loss Account Reserve -0.3% -0.3% 1.4%
Shareholder Funds 99.6% 99.6% 85.4%
Capital Employed - - -
Total Assets Less Current Liabilities 99.8% 99.8% 93.1%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Liquidity Ratio 15.8 15.8 8.2
Solvency Ratio 269.6 269.6 6.8
Reserves to Assets 0.0 0.0 0.0
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 2
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2012 31-Dec-2011
Assets 962,569,000 962,569,000 53,472,000
Debt 3,571,000 3,571,000 7,812,000
Net Assets/Debt 958,998,000 958,998,000 45,660,000

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet indicates the substantial net assets of a large company. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around SL1 3WE
UCB PHARMA LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
DARWIN DISCOVERY LIMITED
208 Bath Road, Slough, Berkshire, SL1 3WE
CELLTECH R&D LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
CELLTECH GROUP LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
UCB BRITISH PENSION TRUST LIMITED
208 Bath Road, Slough, SL1 3WE
CELLTECH PENSION TRUSTEES LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE
Document Filings
Confirmation statement made on 20 July 2025 with no updates
Appointment of Mr Nico Victor Reynders as a director on 1 December 2024
Termination of appointment of Claire Brading as a director on 1 December 2024
Termination of appointment of Olufunlayo Modupe Oluwa as a director on 1 December 2024
Confirmation statement made on 20 July 2024 with no updates
Appointment of Olufunlayo Modupe Oluwa as a director on 1 January 2024
Termination of appointment of Mark Glyn Hardy as a director on 1 October 2023
Termination of appointment of Mark Glyn Hardy as a secretary on 1 October 2023
Confirmation statement made on 20 July 2023 with no updates
Confirmation statement made on 20 July 2022 with no updates
Auditor's resignation
Confirmation statement made on 20 July 2021 with no updates
Director's details changed for Claire Brading on 1 January 2021
Appointment of Claire Brading as a director on 1 January 2021
Termination of appointment of Dan Coombes as a director on 1 January 2021
Confirmation statement made on 20 July 2020 with no updates
Confirmation statement made on 20 July 2019 with no updates
Director's details changed for Mr Yogesh Khatri on 14 March 2019
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free